Auteurs
Analysis
Allemagne
Racine
Analysis
Allemagne
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Erland Erdmann »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Erkki Vartiainen < Erland Erdmann < Erle C. Ellis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
001B75 (2011) Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Christian Funck-Brentano [France] ; Emilio Vanoli [Italie] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Piotr Ponikowski [Pologne] ; Michael Goulder [Royaume-Uni] ; Wilfried Meyer [Allemagne] ; Philippe Lechat [France] ; Ronnie Willenheimer [Suède]Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial
002479 (2006) Ronnie Willenheimer [Suède] ; Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Christian Funck-Brentano [France] ; Erland Erdmann [Allemagne] ; Wilfried R. Meyer [Allemagne]Comment on “Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS‐III, by JGF Cleland and others”
002680 (2005) Ronnie Willenheimer [Suède] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Allan Skene [Royaume-Uni] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France]Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence : Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III
002729 (2004) Ronnie Willenheimer [Suède] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Bernard Silke [Irlande (pays)] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France]Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS‐III

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Bisoprolol
4Enalapril
4Heart failure
2ACE inhibitor
2Antihypertensive agent
2Cardiology
2Chronic heart failure
2Cibis
2Clinical practice
2European society
2Guideline
2Hospitalisation
2Monotherapy phase
2Second drug
2Sudden death
2Target dose
2Treatment
1Acei
1American college
1Beta blocking agent
1Better chance
1Blocker
1Cardiac insufficiency bisoprolol study
1Cardiocirculatory arrest
1Cardiology meeting
1Cardiovascular causes
1Cardiovascular disease
1Central telephone randomisation procedure
1Chronic
1Cleland
1Clinical trial
1Coll cardiol
1Combination therapy
1Confidence interval
1Congestive heart failure
1Decrease hospitalisation
1Dos
1Drug
1Drug treatment
1Early introduction
1Early stages
1Elderly patients
1Endpoint
1Endpoint evaluation
1Enzyme inhibitors
1European journal
1Event rate
1Fewer patients
1First treatment
1Follath
1Heart rate
1Hospitalization
1Independent endpoint committee
1Individual judgement
1Inhibitor
1Initial monotherapy
1Lancet
1Maintenance dose
1Merck kgaa
1Metoprolol cryxl
1Monotherapy
1Morbidity
1Mortalityymorbidity trials
1Nyha class
1Open design
1Operative conduct
1Optimal order
1Optimum doses
1Optimum time interval
1Plasma norepinephrine
1Premature treatment withdrawals
1Primary endpoint
1Primary objective
1Randomisation
1Randomised
1Randomised patients
1Randomization
1Randomized trials
1Renal insufficiency
1Respective agents
1Result
1Sample size
1Second agent
1Second step
1Separate adjustment
1Serum creatinine
1Show superiority
1Side effect
1Side effects
1Standard therapy
1Statistical analysis
1Study group
1Study medication
1Such case
1Survival
1Symptomatic heart failure
1Target doses
1Time point
1Titration steps
1Treatment initiation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Erland Erdmann" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Erland Erdmann" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Erland Erdmann
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024